Alexander M. Haydl

Based in Ingelheim (Germany), Alex is a Laboratory Head in the Department for Chemical Development and a Product Owner for the development of digital tools for process development. In his role of following the principles of ambidextry with ‘exploitation’ and ‘exploration’ as key strategies for innovation, Alex oversees and actively urges the development of active pharmaceutical ingredients (API) for new therapeutic areas at Boehringer Ingelheim.

On the one hand, he is active scaling up complex chemical procedures including the transfer to commercial site, levers CDMO management and manages raw material procurement as well as supply chain strategies. On the other hand, as part of an agile team, he rethinks and remodels the paradigm of ‘analog’ process development, reframing it to a digital realm. Alex is happy to have the opportunity to serve as a coach and a role model being not only curious and innovative but also highly energetic and people centric. Aspired to inspire, he infects the teams and co-workers surrounding him with a high level of energy, optimism, trust, passion, and curiosity and furthermore manages a great triathlon between life, his career at Boehringer Ingelheim and his everlasting learning ambitions within his current project, pursuing an MBA at the Gutenberg Business School at the University of Mainz with the aid of Boehringer Ingelheim.

Alex is a Chemist and Business Economist by training. After his Post Doc at the University of California in Berkeley in the Group of Prof. John Hartwig on transition metal cross-coupling reactions, he started his career in the Department of Chemical Synthesis at BASF (Germany), working several years in R&D on some current major innovations which resulted in over 25 patents and about 15 publications. By chance, Alex migrated then in 2021 to another industry field, joining ‘The Boehringer Ingelheim Family’ in 2021 in the Department for Chemical Development Germany.